ArticleThe Biochemical journal2025
DNA binding of an RNA helicase bacterial transcription terminator.
Article in The Biochemical journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Distinct Spatial Organisation of Rho and RNA Polymerase in Salmonella Cells.Molecular microbiology · 2026Article
- The bacterial transcription terminator, Rho, functions as an RNA:DNA hybrid (RDH) helicase in vivo.The Biochemical journal · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The bacterial transcription terminator Rho is a hexameric ATP-dependent RNA helicase that dislodges elongating RNA polymerases. It has an N-terminal primary RNA binding site (PBS) on each subunit and a C-terminal secondary RNA binding site at the central channel. Here, we show that Rho also binds to linear longer double-stranded DNAs (dsDNAs) and the circular plasmids nonspecifically using its PBS. However, this interaction could be competed efficiently by single-stranded DNA (ssDNA), dC34. Long dsDNA (3.5 kb) at the PBS activates short oligo C RNA-mediated ATPase activity at the secondary binding site (SBS). The pre-bound Rho to this long DNA reduces the rate and efficiency of its transcription termination activities in vitro. Elevated concentrations of Rho reduced the in vitro transcription level suggesting that Rho might also function as a nonspecific repressor of gene expression under certain conditions. In the mid-log phase culture, Rho molecules were concentrated at the poles and along the membrane. In contrast, the Rho hexamers were observed to be distributed over the bacterial chromosome in the stationary phase likely in a hyper-oligomeric state composed of oligomers of hexamers. We propose that Rho molecules not engaged in the transcription termination process could use the bacterial chromosome as a "resting surface". This way the "idle" DNA-bound Rho molecules could be kept away from accidentally loading onto the nascent RNA and initiating unwanted transcription termination.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.